Dongkook Lifescience Holds Academic Symposium for Mongolian Medical Professionals

Dongkook Lifescience, a company specializing in contrast agents, announced on June 26 that it had successfully held an online symposium on TACE (Transarterial Chemoembolization) for interventional medical professionals in Mongolia during May and June.

The symposium was organized in response to ongoing inquiries from Mongolian medical professionals regarding the use of Pateodol, an iodized oil preparation, and the TACE procedure protocol. Pateodol is a contrast agent containing iodized oil that is used during TACE procedures for patients with hepatocellular carcinoma, helping with drug delivery and the embolization process.

Dongkook Lifescience planned the event as an online symposium to provide educational content that local medical staff could reference in clinical settings. The lecture was delivered by Professor Shin Jihoon, President of the Korean Society of Interventional Radiology and a faculty member in the Department of Radiology at Asan Medical Center. Professor Shin covered topics including indications for TACE, the clinical role of Pateodol, the types and mixing ratios of accompanying drugs, actual procedural protocols, methods to improve procedural precision using X-ray (CBCT), and important precautions during procedures.

Interventional medical professionals from major regional base hospitals and diagnostic treatment centers across Mongolia, including the Second National Central Hospital of Mongolia as well as hospitals in Dornod, Khovd, Uvurkhangai, Omnogovi, Khentii, Darkhan, and Orkhon, also participated in the symposium.

Dongkook Lifescience plans to continue expanding its academic support activities for global medical professionals. The company’s strategy is to increase its credibility in the global market not merely by supplying products, but by supporting local healthcare professionals in strengthening their clinical capabilities and improving access to care.

A representative from Dongkook Lifescience stated, “This online symposium is especially meaningful as it is an academic exchange program that originated from the clinical needs of Mongolian medical professionals,” adding, “We will continue to expand educational and academic support activities for overseas healthcare providers to enhance the clinical use of major products, including Pateodol.”

This content was produced with the assistance of AI translation services.